Advertisement
UK markets closed
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • CRUDE OIL

    83.40
    +0.04 (+0.05%)
     
  • GOLD FUTURES

    2,334.80
    -7.30 (-0.31%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • Bitcoin GBP

    53,363.88
    -232.94 (-0.43%)
     
  • CMC Crypto 200

    1,429.01
    +14.25 (+1.01%)
     
  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     
  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     

VKTX or ENTA: What to Expect from Revenue Growth in 2019

VKTX or ENTA: What to Expect from Revenue Growth in 2019

What Are Analysts Recommending for VKTX and ENTA?(Continued from Prior Part)Growth drivers In November 2018, Viking Therapeutics (VKTX) issued a press release announcing positive results from its Phase 2 trial evaluating the efficacy of the 1-mg dose